Jian‐Yong Ding

988 total citations
32 papers, 764 citations indexed

About

Jian‐Yong Ding is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jian‐Yong Ding has authored 32 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Jian‐Yong Ding's work include RNA modifications and cancer (8 papers), Epigenetics and DNA Methylation (5 papers) and Ubiquitin and proteasome pathways (4 papers). Jian‐Yong Ding is often cited by papers focused on RNA modifications and cancer (8 papers), Epigenetics and DNA Methylation (5 papers) and Ubiquitin and proteasome pathways (4 papers). Jian‐Yong Ding collaborates with scholars based in China, United States and Japan. Jian‐Yong Ding's co-authors include Jie Gu, Di Ge, Zongwu Lin, Guangyin Zhao, Jiahao Jiang, Chunlai Lu, Haikun Wang, Jingwei Jiang, Jing Guo and Jing Gao and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Jian‐Yong Ding

28 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian‐Yong Ding China 17 519 270 206 131 127 32 764
Joseph Clara United States 6 356 0.7× 317 1.2× 186 0.9× 76 0.6× 153 1.2× 12 638
Caiwen Du China 15 473 0.9× 416 1.5× 250 1.2× 168 1.3× 92 0.7× 45 803
Richard J. Salamone United States 5 500 1.0× 431 1.6× 189 0.9× 191 1.5× 96 0.8× 5 798
Melissa M. Wolf United States 7 502 1.0× 228 0.8× 306 1.5× 128 1.0× 103 0.8× 13 720
Luis J. Schwarz Peru 10 511 1.0× 319 1.2× 317 1.5× 97 0.7× 69 0.5× 17 808
Maozhen Tian United States 8 540 1.0× 364 1.3× 179 0.9× 80 0.6× 76 0.6× 8 760
Adrian P. Rybak Canada 12 450 0.9× 265 1.0× 157 0.8× 174 1.3× 55 0.4× 17 644
Shuangbing Xu China 21 775 1.5× 370 1.4× 317 1.5× 182 1.4× 142 1.1× 42 1.1k
Loredana Militello Italy 9 355 0.7× 319 1.2× 205 1.0× 197 1.5× 106 0.8× 19 746
Prashanth Prithviraj Australia 13 319 0.6× 405 1.5× 155 0.8× 193 1.5× 192 1.5× 28 753

Countries citing papers authored by Jian‐Yong Ding

Since Specialization
Citations

This map shows the geographic impact of Jian‐Yong Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian‐Yong Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian‐Yong Ding more than expected).

Fields of papers citing papers by Jian‐Yong Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian‐Yong Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian‐Yong Ding. The network helps show where Jian‐Yong Ding may publish in the future.

Co-authorship network of co-authors of Jian‐Yong Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Jian‐Yong Ding. A scholar is included among the top collaborators of Jian‐Yong Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian‐Yong Ding. Jian‐Yong Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gao, Jian, Siyang Wang, Jiahao Jiang, et al.. (2025). Clinical significance of positron emission tomography-computed tomography in the classification of thymic tumors. Interdisciplinary CardioVascular and Thoracic Surgery. 40(3).
3.
Ding, Jian‐Yong, Qiang Nie, Zhen‐Bin Qiu, et al.. (2025). Advantages of robotic-assisted thoracic surgery after neoadjuvant therapy in NSCLC: A propensity score–matched analysis. European Journal of Surgical Oncology. 51(8). 110022–110022.
4.
Zhang, Li, Jian‐Yong Ding, Xuefeng Xia, et al.. (2023). P1.21-05 The Upregulated Expression of IGF2BP2 Predicts Poor Prognosis in Lung Adenocarcinoma and Affects Immune Microenvironment and Drug Sensitivity. Journal of Thoracic Oncology. 18(11). S235–S236. 1 indexed citations
5.
Gao, Jian, Shuai Wang, Jiahao Jiang, et al.. (2023). Immunotherapy of thymic epithelial tumors: molecular understandings and clinical perspectives. Molecular Cancer. 22(1). 70–70. 21 indexed citations
6.
7.
Gao, Jian, Chun Jin, Pengfei Zhang, et al.. (2022). Elevated circASCC3 limits antitumor immunity by sponging miR-432–5p to upregulate C5a in non-small cell lung cancer. Cancer Letters. 543. 215774–215774. 16 indexed citations
8.
Lv, Yang, Qingyang Feng, Ye Wei, et al.. (2020). Benefits of multi‐disciplinary treatment strategy on survival of patients with colorectal cancer liver metastasis. SHILAP Revista de lepidopterología. 10(3). e121–e121. 12 indexed citations
9.
Gao, Jing, et al.. (2019). Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer. Clinical & Translational Oncology. 21(10). 1287–1301. 81 indexed citations
10.
Xiong, Dian, Shu‐Qiang Zhu, Yongbing Wu, et al.. (2018). Ring finger protein 38 promote non-small cell lung cancer progression by endowing cell EMT phenotype. Journal of Cancer. 9(5). 841–850. 18 indexed citations
11.
Wang, Lin, Lin Shi, Jie Gu, et al.. (2018). CXCL5 regulation of proliferation and migration in human non-small cell lung cancer cells. Journal of Physiology and Biochemistry. 74(2). 313–324. 30 indexed citations
12.
Jin, Chun, et al.. (2018). Loss of UHRF2 Is Associated With Non-small Cell Lung Carcinoma Progression. Journal of Cancer. 9(17). 2994–3005. 12 indexed citations
13.
14.
Gu, Jie, Fengkai Xu, Guangyin Zhao, et al.. (2015). Capn4 promotes non-small cell lung cancer progression via upregulation of matrix metalloproteinase 2. Medical Oncology. 32(3). 51–51. 25 indexed citations
15.
Zhao, Guangyin, Zongwu Lin, Chunlai Lu, et al.. (2014). USP7 overexpression predicts a poor prognosis in lung squamous cell carcinoma and large cell carcinoma. Tumor Biology. 36(3). 1721–1729. 68 indexed citations
16.
Gu, Jie, et al.. (2013). CXCR4 heterogeneous expression in esophageal squamous cell cancer and stronger metastatic potential with CXCR4-positive cancer cells. Diseases of the Esophagus. 27(3). 294–302. 23 indexed citations
17.
Yamamoto, Norio, Michiharu Daito, Jian‐Yong Ding, et al.. (2013). An Optimal mRNA Marker for OSNA (One-step Nucleic Acid Amplification) Based Lymph Node Metastasis Detection in Colorectal Cancer Patients. Japanese Journal of Clinical Oncology. 43(3). 264–270. 21 indexed citations
18.
Gu, Jie, Jian‐Yong Ding, Chunlai Lu, et al.. (2013). Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer. Lung Cancer. 81(2). 259–265. 73 indexed citations
19.
Huang, Yan‐Jiun, Hang Jin, Yingtao Liu, et al.. (2010). FSH inhibits ovarian cancer cell apoptosis by up-regulating survivin and down-regulating PDCD6 and DR5. Endocrine Related Cancer. 18(1). 13–26. 51 indexed citations
20.
Ding, Jian‐Yong, Di Ge, Weigang Guo, & Chunlai Lu. (2008). Diazoxide-Mediated Growth Inhibition in Human Lung Cancer Cells via Downregulation of β-Catenin-Mediated Cyclin D1 Transcription. Lung. 187(1). 61–67. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph Clara Breakdown of academic impact, for papers by Caiwen Du Breakdown of academic impact, for papers by Richard J. Salamone Breakdown of academic impact, for papers by Melissa M. Wolf Breakdown of academic impact, for papers by Luis J. Schwarz Breakdown of academic impact, for papers by Maozhen Tian Breakdown of academic impact, for papers by Adrian P. Rybak Breakdown of academic impact, for papers by Shuangbing Xu Breakdown of academic impact, for papers by Loredana Militello Breakdown of academic impact, for papers by Prashanth Prithviraj
Rankless by CCL
2026